After nearly four months of strength, U.S. stocks showed their first chink in the armor as all three major indices dropped more than 2% during the week......
(read more)
April 23 - News - Comments
Johnson & Johnson (NYSE:JNJ) has been considered a dividend growth star for a number of years now. They have increased their dividend for 50 consecutive......
(read more)
April 18 - News - Comments
Is AmerisourceBergen Corp. (NYSE:ABC) going to take off soon? Investors who are in the know are turning less bullish. The number of long hedge fund bets......
(read more)
April 10 - News - Comments
Medical care is expensive, and the best way to lower costs is to keep patients out of hospitals. There are a few companies positioning themselves through......
(read more)
March 22 - News - Comments
Cardinal Health, Inc. (NYSE:CAH) shares dropped more than 10% this week after Walgreen Company (NYSE:WAG) announced it wouldn’t renew its contract......
(read more)
March 21 - News - Comments
Sometimes it doesn’t matter which way the economic trends swing — the market just wants to head lower. Just yesterday, the market shed a few......
(read more)
March 19 - News - Comments
“My late father used to say that no quality of human life was more important than dignity,” Yale law professor Stephen Carter recently commented......
(read more)
March 19 - News - Comments
Navidea Biopharmaceuticals Inc. (NYSEMKT:NAVB) is experiencing a case of “sell the news” today. The company got a mid-day Food and Drug Administration......
(read more)
March 14 - News - Comments
Since everyone loves a winner, it’s reasonable to assume that everyone hates a loser — everyone but short sellers, at least. These contrarian......
(read more)
March 6 - News - Comments
Cardinal Health, Inc. (NYSE:CAH) is buying privately held AssuraMed, a supplier of products for home use to treat diabetes, wounds, and incontinence,......
(read more)
March 1 - News - Comments
Over the past year, I (along with many other investors) have recognized the awesome beauty of dividend stocks. Once considered the stodgy old men of......
(read more)
February 4 - News - Comments
Although shares of Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB) are relatively unchanged over the trailing-12-month period, ask shareholders and they......
(read more)
January 15 - News - Comments
Rite Aid Corporation (NYSE:RAD) is a major growth opportunity, but also a takeover candidate. The drug company is up over 25% since last week thanks to......
(read more)
December 26 - Stock Analysis - Comments
Ray Dalio founded Bridgewater Associates out of his apartment in 1973 and after 28 years, gave up the CEO title last year. Dalio now serves as “mentor......
(read more)
December 21 - Hedge Funds - Comments
Paul Tudor Jones founded Tudor Investment in 1980 and has a net worth over $3 billion. His fund focuses on short term trading and charges a fee that is......
(read more)
November 30 - Hedge Funds - Comments
In my last article on Walgreen Company (NYSE:WAG), I gave light on pressing issues revolving around the world’s largest drugstore. After a rough 2012......
(read more)
October 10 - Stock Analysis - Comments
David Einhorn’s Greenlight Capital returned 15.9% in 2010, and 21.5% since its inception in 1996. It is one of the hedge funds we follow very closely......
(read more)
February 17 - Hedge Funds - Comments
Roberto Mignone’s Bridger Management follows a long/short strategy after extensively researching companies. Their analysts do the legwork......
(read more)
February 14 - Uncategorized - Comments
Roberto Mignone’s Bridger Management keeps their returns extremely secret. They do extensive analysis and follow a long/short strategy. Wall Street......
(read more)
December 18 - Hedge Funds - Comments
